Trans-NIH A-T Research Working Group

The NIH has developed a research plan for ataxia-telangiectasia (A-T) in response to interest from the scientific, medical, and patient communities, as well as from Congress.

The Trans-NIH A-T Research Working Group, which includes the National Institute of Neurological Disorders and Stroke (NINDS), National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHBLI), National Human Genome Research Institute (NHGRI), National Institute on Aging (NIA), National Institute of Child Health and Human Development (NICHD), National Institute on Deafness and Other Communication Disorders (NIDCD), and the National Institute of Environmental Health Sciences (NIEHS), in conjunction with A-T Ease Foundation, is inviting research grant applications aimed at understanding or treating Ataxia-Telangiectasia (A-T).

The broad objectives are to:

The following NIH grant mechanisms are available for researchers:

Inquiries regarding the NIH Program Announcement for A-T, should be directed to:

Dan Tagle, PhD, Program Director, NINDS
t: 301-496-5745

A-T Ease Foundation Partnership with the NIH

A partnership has been entered into between A-T Ease Foundation and several institutes at the NIH.  Under this partnership unsuccessful NIH applicants can authorize the distribution of their NIH review summary statements to A-T Ease to be considered for funding.

Please direct your inquiries to